Human chorionic gonadotrophin (HCG) may substitute FSH to complete follicular growth in
IVF cycles. This may be useful in the prevention of ovarian hyperstimulation syndrome …

Objective to evaluate the effect of the addition of low dose human chorionic gonadotropin
(hCG) to human menopausal gonadotropin (HMG) throughout the early follicular phase in …

OBJECTIVE: To assess the efficacy and safety of hCG to induce follicular stimulation.
DESIGN: Systematic literature searches of PubMed, EMBASE, CENTRAL, and SciSearch …

Knowledge of the physiology of folliculogenesis has led to a better understanding of the role
of LH activity in this process. This role has been investigated in the setting of ovarian …

Purpose: The aim of the study was to assess the effect of the addition of low-dose human
chorionic gonadotropin (hCG) to ovarian stimulation with recombinant follicle stimulating …

STUDY QUESTION Is it possible to define an optimal dose of hCG in combination with rFSH
from the first day of stimulation in the GnRH agonist protocol applied to IVF? SUMMARY …

The widely applied practice of a gonadotrophin dose increase in case of low response is not
on an evidence-based level and not efficacious. All known comparative studies failed to …

STUDY QUESTION Does an artificially induced FSH surge at the time of hCG trigger
improve IVF/ICSI outcomes? SUMMARY ANSWER An additional FSH bolus administered at …

OBJECTIVE: To prove that low-dose hCG alone can be clinically used to replace FSH-
containing gonadotropins to complete controlled ovarian hyperstimulation (COH). DESIGN …

BACKGROUND Since the most recent Cochrane review on hMG versus rFSH for controlled
ovarian hyperstimulation following a long down-regulation protocol, several new trials have …